Agilent TechnologiesAEarnings & Financial Report
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting IPO of Agilent stock was the largest in the history of Silicon Valley at the time.
A Q4 2025 Key Financial Metrics
Revenue
$1.9B
Gross Profit
$990.0M
Operating Profit
$443.0M
Net Profit
$434.0M
Gross Margin
53.2%
Operating Margin
23.8%
Net Margin
23.3%
YoY Growth
9.4%
EPS
$1.53
Financial Flow
Agilent Technologies Q4 2025 Financial Summary
Agilent Technologies reported revenue of $1.9B for Q4 2025, with a net profit of $434.0M (23.3% margin). Cost of goods sold was $871.0M, operating expenses totaled $547.0M.
Key Financial Metrics
| Total Revenue | $1.9B |
|---|---|
| Net Profit | $434.0M |
| Gross Margin | 53.2% |
| Operating Margin | 23.8% |
| Report Period | Q4 2025 |
Agilent Technologies Annual Revenue by Year
Agilent Technologies annual revenue history includes year-by-year totals (for example, 2025 revenue was $6.9B).
| Year | Annual Revenue |
|---|---|
| 2025 | $6.9B |
| 2024 | $6.5B |
| 2023 | $6.8B |
| 2022 | $6.8B |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.66B | $1.57B | $1.58B | $1.70B | $1.68B | $1.67B | $1.74B | $1.86B |
| YoY Growth | -5.6% | -8.4% | -5.6% | 0.8% | 1.4% | 6.0% | 10.1% | 9.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $10.95B | $10.86B | $11.00B | $11.85B | $11.91B | $12.16B | $12.23B | $12.73B |
| Liabilities | $4.76B | $4.64B | $5.09B | $5.95B | $5.89B | $6.02B | $5.86B | $5.99B |
| Equity | $6.19B | $6.21B | $5.90B | $5.90B | $6.03B | $6.14B | $6.37B | $6.74B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $485.0M | $333.0M | $452.0M | $481.0M | $431.0M | $221.0M | $362.0M | $545.0M |
Other Health Care Companies
TECH
Bio-Techne
Revenue
$295.9M
Net Profit
$38.0M
CRL
Charles River Laboratories
Revenue
$994.2M
Net Profit
$-276.6M
DHR
Danaher Corporation
Revenue
$6.1B
Net Profit
$908.0M
IQV
IQVIA
Revenue
$4.4B
Net Profit
$514.0M
MTD
Mettler Toledo
Revenue
$1.1B
Net Profit
$285.8M
TMO
Thermo Fisher Scientific
Revenue
$11.1B
Net Profit
$1.6B
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B